Plasma Industries processes approximately 1.8 million liters of internationally sourced plasma by pharmaceutical multinational partners.
They contract us to reduce their capital expenditure and costs of manufacturing, to have access to our specialized manufacturing methods, as well as gain extra capacity to mitigate the risk of supply interruptions or unanticipated spikes in demand.
When you take the leap to move from the laboratory to a GMP manufacturing setting, our experience as a CMO will help you establish the right methods to reduce any project risk which might occur on the road to manufacture.
From due diligence till the identification of Critical Process Parameters, Plasma Industries can service you with: